speb/financial-data huggingface dataset:
CKX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
CKX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 242270.00
CKX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -86189.00
CKX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 86188.00
CKX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 186883.00
CKX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4403854.00
CKX income_statement (quarterly, 2025-09-30) — Gross Profit: 214048.00
CKX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
CKX income_statement (quarterly, 2025-09-30) — Interest Income: 50401.00
CKX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 50401.00
CKX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
CKX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 18878359.00
CKX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 141105.00
CKX balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 3621391.00
CKX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CKX income_statement (quarterly, 2025-09-30) — Net Income: 166304.00
CKX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 166304.00
CKX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 166304.00
CKX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 166304.00
CKX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 166304.00
CKX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 166304.00
CKX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 166304.00
CKX income_statement (quarterly, 2025-09-30) — Net Interest Income: 50401.00
CKX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
CKX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 50401.00
CKX balance_sheet (quarterly, 2025-09-30) — Net PPE: 4305398.00
CKX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 141105.00
CKX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 18878359.00
CKX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 109819.00
CKX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 109819.00
CKX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -58186.00
CKX income_statement (quarterly, 2025-09-30) — Normalized Income: 98215.48
CKX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 242270.00
CKX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -86189.00
CKX income_statement (quarterly, 2025-09-30) — Operating Income: 27165.00
CKX income_statement (quarterly, 2025-09-30) — Operating Revenue: 232639.00
CKX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2053129.00
CKX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 177508.00
CKX income_statement (quarterly, 2025-09-30) — Other Gand A: 186883.00
CKX income_statement (quarterly, 2025-09-30) — Other Income Expense: 86188.00
CKX balance_sheet (quarterly, 2025-09-30) — Other Properties: 782463.00
CKX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2166088.00
CKX balance_sheet (quarterly, 2025-09-30) — Payables: 111639.00
CKX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 111639.00
CKX income_statement (quarterly, 2025-09-30) — Pretax Income: 163754.00
CKX balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CKX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
CKX balance_sheet (quarterly, 2025-09-30) — Receivables: 44401.00
CKX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 18591.00
CKX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 837.00
CKX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CKX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 16065238.00
CKX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CKX cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 141105.00
CKX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 186883.00
CKX balance_sheet (quarterly, 2025-09-30) — Share Issued: 2102595.00
CKX income_statement (quarterly, 2025-09-30) — Special Income Charges: 86188.00
CKX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 0.00
CKX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 18878359.00
CKX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 18878359.00
CKX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 18099.48
CKX income_statement (quarterly, 2025-09-30) — Tax Provision: -2550.00
CKX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CKX balance_sheet (quarterly, 2025-09-30) — Total Assets: 19159457.00
CKX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 18878359.00
CKX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 18878359.00
CKX income_statement (quarterly, 2025-09-30) — Total Expenses: 205474.00
CKX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 281098.00
CKX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4415217.00
CKX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CKX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 113353.00
CKX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 86188.00
CKX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 86188.00
CKX balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 49466.00
CKX balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 620216.00
CKX balance_sheet (quarterly, 2025-09-30) — Working Capital: 14463142.00
CKX income_statement (annual, 2025-12-31) — +Operating Expense: 687441.00
CKX income_statement (quarterly, 2025-12-31) — +Operating Expense: 139082.00
CKX income_statement (annual, 2025-12-31) — +Total Revenue: 838543.00
CKX income_statement (quarterly, 2025-12-31) — +Total Revenue: 121784.00
CKX balance_sheet (annual, 2025-12-31) — Accounts Payable: 87985.00
CKX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 87985.00
CKX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 41705.00
CKX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 41705.00
CKX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -99167.00
CKX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -99167.00
CKX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 3374002.00
CKX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 3374002.00
CKX income_statement (annual, 2025-12-31) — Basic Average Shares: 2045622.00
CKX income_statement (annual, 2025-12-31) — Basic EPS: 1.47
CKX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3421576.00
CKX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 7851889.00
CKX balance_sheet (annual, 2025-12-31) — Capital Stock: 59335.00
CKX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 59335.00
CKX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 18010108.00
CKX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 18010108.00
CKX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 18010108.00
CKX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 18010108.00
CKX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -147614.00
CKX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CKX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 14276516.00
CKX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 10034885.00
CKX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 459630.00
CKX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 123334.00
CKX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 196374.00
CKX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 168962.00
CKX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 466219.00
CKX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 449304.00
CKX cash_flow (annual, 2025-12-31) — Change In Working Capital: 662593.00
CKX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 618266.00
CKX cash_flow (annual, 2025-12-31) — Changes In Cash: 14588532.00
CKX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 10158219.00
CKX balance_sheet (annual, 2025-12-31) — Common Stock: 59335.00
CKX balance_sheet (quarterly, 2025-12-31) — Common Stock: 59335.00
CKX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 21445412.00
CKX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 21445412.00
CKX cash_flow (annual, 2025-12-31) — Common Stock Payments: -147614.00
CKX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
CKX income_statement (annual, 2025-12-31) — Cost Of Revenue: 67807.00
CKX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9180.00
CKX balance_sheet (annual, 2025-12-31) — Current Assets: 18063055.00
CKX balance_sheet (quarterly, 2025-12-31) — Current Assets: 18063055.00
CKX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 173369.00
CKX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 173369.00
CKX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 173369.00
CKX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 173369.00
CKX balance_sheet (annual, 2025-12-31) — Current Liabilities: 730402.00
CKX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 730402.00
CKX cash_flow (annual, 2025-12-31) — Deferred Income Tax: 341698.00
CKX cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 219773.00
CKX cash_flow (annual, 2025-12-31) — Deferred Tax: 341698.00
CKX cash_flow (quarterly, 2025-12-31) — Deferred Tax: 219773.00
CKX cash_flow (annual, 2025-12-31) — Depletion: 126.00
CKX cash_flow (quarterly, 2025-12-31) — Depletion: 0.00
CKX cash_flow (annual, 2025-12-31) — Depreciation: 3109.00
CKX cash_flow (quarterly, 2025-12-31) — Depreciation: 711.00
CKX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3235.00
CKX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 711.00
CKX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3109.00
CKX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 711.00
CKX income_statement (annual, 2025-12-31) — Diluted Average Shares: 2045622.00
CKX income_statement (annual, 2025-12-31) — Diluted EPS: 1.47
CKX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 3009972.00
CKX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2567053.00
CKX income_statement (annual, 2025-12-31) — EBIT: 83295.00
CKX income_statement (quarterly, 2025-12-31) — EBIT: -26478.00
CKX income_statement (annual, 2025-12-31) — EBITDA: 86530.00
CKX income_statement (quarterly, 2025-12-31) — EBITDA: -25767.00
CKX cash_flow (annual, 2025-12-31) — End Cash Position: 18010108.00
CKX cash_flow (quarterly, 2025-12-31) — End Cash Position: 18010108.00
CKX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -147614.00
CKX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
CKX cash_flow (annual, 2025-12-31) — Free Cash Flow: 459630.00
CKX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 123334.00
CKX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -3557868.00
CKX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -3282469.00
CKX income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 3557868.00
CKX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 3282469.00
CKX income_statement (annual, 2025-12-31) — General And Administrative Expense: 687441.00
CKX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 139082.00
CKX balance_sheet (annual, 2025-12-31) — Gross PPE: 4321880.00
CKX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4321880.00
CKX income_statement (annual, 2025-12-31) — Gross Profit: 770736.00
CKX income_statement (quarterly, 2025-12-31) — Gross Profit: 112604.00
CKX cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CKX cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CKX balance_sheet (annual, 2025-12-31) — Income Tax Payable: 469048.00
CKX balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 469048.00
CKX income_statement (annual, 2025-12-31) — Interest Income: 335539.00
CKX income_statement (quarterly, 2025-12-31) — Interest Income: 117059.00
CKX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 335539.00
CKX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 117059.00
CKX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
CKX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
CKX balance_sheet (annual, 2025-12-31) — Invested Capital: 21445412.00
CKX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 21445412.00
CKX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 14276516.00
CKX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 10034885.00
CKX balance_sheet (annual, 2025-12-31) — Land And Improvements: 3688788.00
CKX balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 3688788.00
CKX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -147614.00
CKX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CKX income_statement (annual, 2025-12-31) — Net Income: 3009972.00
CKX income_statement (quarterly, 2025-12-31) — Net Income: 2567053.00
CKX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 3009972.00
CKX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2567053.00
CKX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 3009972.00
CKX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2567053.00
CKX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3009972.00
CKX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2567053.00
CKX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3009972.00
CKX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2567053.00
CKX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 3009972.00
CKX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2567053.00
CKX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 3009972.00
CKX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2567053.00
CKX income_statement (annual, 2025-12-31) — Net Interest Income: 335539.00
CKX income_statement (quarterly, 2025-12-31) — Net Interest Income: 117059.00
CKX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 5908492.00
CKX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 2166089.00
CKX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 335539.00
CKX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 117059.00
CKX balance_sheet (annual, 2025-12-31) — Net PPE: 4222713.00
CKX balance_sheet (quarterly, 2025-12-31) — Net PPE: 4222713.00
CKX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 8368024.00
CKX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 7868796.00
CKX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 21445412.00
CKX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 21445412.00
CKX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 0.00
CKX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 0.00
CKX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 109954.00
CKX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 109954.00
CKX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
CKX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
CKX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 109954.00
CKX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 109954.00
CKX income_statement (annual, 2025-12-31) — Normalized EBITDA: -3471338.00
CKX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3308236.00
CKX income_statement (annual, 2025-12-31) — Normalized Income: 317060.81
CKX income_statement (quarterly, 2025-12-31) — Normalized Income: 68936.49
CKX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 459630.00
CKX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 123334.00
CKX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -3557868.00
CKX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -3282469.00
CKX income_statement (annual, 2025-12-31) — Operating Income: 83295.00
CKX income_statement (quarterly, 2025-12-31) — Operating Income: -26478.00
CKX income_statement (annual, 2025-12-31) — Operating Revenue: 838543.00
CKX income_statement (quarterly, 2025-12-31) — Operating Revenue: 121784.00
CKX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2053129.00
CKX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2053129.00
CKX balance_sheet (annual, 2025-12-31) — Other Current Assets: 11242.00
CKX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 11242.00
CKX income_statement (annual, 2025-12-31) — Other Gand A: 687441.00
CKX income_statement (quarterly, 2025-12-31) — Other Gand A: 139082.00
CKX income_statement (annual, 2025-12-31) — Other Income Expense: 3557934.00
CKX income_statement (quarterly, 2025-12-31) — Other Income Expense: 3282469.00
CKX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 66.00
CKX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 0.00
CKX balance_sheet (annual, 2025-12-31) — Other Properties: 633092.00
CKX balance_sheet (quarterly, 2025-12-31) — Other Properties: 633092.00
CKX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
CKX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
CKX balance_sheet (annual, 2025-12-31) — Payables: 557033.00
CKX balance_sheet (quarterly, 2025-12-31) — Payables: 557033.00
CKX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 557033.00
CKX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 557033.00
CKX income_statement (annual, 2025-12-31) — Pretax Income: 3976768.00
CKX income_statement (quarterly, 2025-12-31) — Pretax Income: 3373050.00
CKX balance_sheet (annual, 2025-12-31) — Properties: 0.00
CKX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CKX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -6750836.00
CKX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 1.00
CKX balance_sheet (annual, 2025-12-31) — Receivables: 41705.00
CKX balance_sheet (quarterly, 2025-12-31) — Receivables: 41705.00
CKX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 67807.00
CKX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9180.00
CKX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3235.00
CKX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 711.00
CKX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -147614.00
CKX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CKX balance_sheet (annual, 2025-12-31) — Retained Earnings: 18632291.00
CKX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 18632291.00
CKX cash_flow (annual, 2025-12-31) — Sale Of Investment: 12659328.00
CKX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 2166088.00
CKX cash_flow (annual, 2025-12-31) — Sale Of PPE: 8368024.00
CKX cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 7868796.00
CKX income_statement (annual, 2025-12-31) — Selling General And Administration: 687441.00
CKX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 139082.00
CKX balance_sheet (annual, 2025-12-31) — Share Issued: 2102595.00
CKX balance_sheet (quarterly, 2025-12-31) — Share Issued: 2102595.00
CKX income_statement (annual, 2025-12-31) — Special Income Charges: 3557868.00
CKX income_statement (quarterly, 2025-12-31) — Special Income Charges: 3282469.00
CKX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
CKX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
CKX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 21445412.00
CKX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 21445412.00
CKX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 21445412.00
CKX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 21445412.00
CKX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 864956.81
CKX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 784352.49
CKX income_statement (annual, 2025-12-31) — Tax Provision: 966796.00
CKX income_statement (quarterly, 2025-12-31) — Tax Provision: 805997.00
CKX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CKX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
CKX balance_sheet (annual, 2025-12-31) — Total Assets: 22285768.00
CKX balance_sheet (quarterly, 2025-12-31) — Total Assets: 22285768.00
CKX balance_sheet (annual, 2025-12-31) — Total Capitalization: 21445412.00
CKX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 21445412.00
CKX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 21445412.00
CKX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 21445412.00
CKX income_statement (annual, 2025-12-31) — Total Expenses: 755248.00
CKX income_statement (quarterly, 2025-12-31) — Total Expenses: 148262.00
CKX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 840356.00
CKX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 840356.00
CKX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4222713.00
CKX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4222713.00
CKX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 109954.00
CKX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 109954.00
CKX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 3641163.00
CKX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 3255991.00
CKX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 469048.00
CKX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 469048.00
CKX income_statement (annual, 2025-12-31) — Total Unusual Items: 3557868.00
CKX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 3282469.00
CKX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 3557868.00
CKX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 3282469.00
CKX balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 49466.00
CKX balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 49466.00
CKX balance_sheet (annual, 2025-12-31) — Treasury Stock: 620216.00
CKX balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 620216.00
CKX balance_sheet (annual, 2025-12-31) — Working Capital: 17332653.00
CKX balance_sheet (quarterly, 2025-12-31) — Working Capital: 17332653.00
CKX income_statement (quarterly, 2026-03-31) — +Operating Expense: 242269.00
CKX income_statement (quarterly, 2026-03-31) — +Total Revenue: 170660.00
CKX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 83045.00
CKX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 18857.00
CKX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -90588.00
CKX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 3374002.00
CKX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2053129.00
CKX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.03
CKX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 18010108.00
CKX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 59335.00
CKX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 12712553.00
CKX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 17957777.00
CKX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -5245224.00
CKX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -52331.00
CKX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -73861.00
CKX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -25214.00
CKX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -99075.00
CKX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -5297555.00
CKX balance_sheet (quarterly, 2026-03-31) — Common Stock: 59335.00
CKX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 21500656.00
CKX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3230.00
CKX balance_sheet (quarterly, 2026-03-31) — Current Assets: 18084585.00
CKX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 139783.00
CKX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 139783.00
CKX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 705188.00
CKX cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 0.00
CKX cash_flow (quarterly, 2026-03-31) — Deferred Tax: 0.00
CKX cash_flow (quarterly, 2026-03-31) — Depletion: 79.00
CKX cash_flow (quarterly, 2026-03-31) — Depreciation: 438.00
CKX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 517.00
CKX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 438.00
CKX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2053129.00
CKX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.03
CKX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 55244.00
CKX income_statement (quarterly, 2026-03-31) — EBIT: -74839.00
CKX income_statement (quarterly, 2026-03-31) — EBITDA: -74322.00
CKX cash_flow (quarterly, 2026-03-31) — End Cash Position: 12712553.00
CKX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -52331.00
CKX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 242269.00
CKX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4321801.00
CKX income_statement (quarterly, 2026-03-31) — Gross Profit: 167430.00
CKX cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CKX balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 482360.00
CKX income_statement (quarterly, 2026-03-31) — Interest Income: 134377.00
CKX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 134377.00
CKX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
CKX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 21500656.00
CKX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -5245224.00
CKX balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 3688788.00
CKX income_statement (quarterly, 2026-03-31) — Net Income: 55244.00
CKX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 55244.00
CKX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 55244.00
CKX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 55244.00
CKX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 55244.00
CKX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 55244.00
CKX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 55244.00
CKX income_statement (quarterly, 2026-03-31) — Net Interest Income: 134377.00
CKX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -5245224.00
CKX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 134377.00
CKX balance_sheet (quarterly, 2026-03-31) — Net PPE: 4231213.00
CKX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 21500656.00
CKX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 109954.00
CKX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 109954.00
CKX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -74322.00
CKX income_statement (quarterly, 2026-03-31) — Normalized Income: 55244.00
CKX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -52331.00
CKX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -9017.00
CKX income_statement (quarterly, 2026-03-31) — Operating Income: -74839.00
CKX income_statement (quarterly, 2026-03-31) — Operating Revenue: 170660.00
CKX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 2053129.00
CKX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 107951.00
CKX income_statement (quarterly, 2026-03-31) — Other Gand A: 242269.00
CKX income_statement (quarterly, 2026-03-31) — Other Income Expense: 9018.00
CKX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 9018.00
CKX balance_sheet (quarterly, 2026-03-31) — Other Properties: 633013.00
CKX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 5245224.00
CKX balance_sheet (quarterly, 2026-03-31) — Payables: 565405.00
CKX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 565405.00
CKX income_statement (quarterly, 2026-03-31) — Pretax Income: 68556.00
CKX balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CKX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -5245224.00
CKX balance_sheet (quarterly, 2026-03-31) — Receivables: 18857.00
CKX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3230.00
CKX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 517.00
CKX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 18687535.00
CKX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
CKX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 242269.00
CKX balance_sheet (quarterly, 2026-03-31) — Share Issued: 2102595.00
CKX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 21500656.00
CKX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 21500656.00
CKX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CKX income_statement (quarterly, 2026-03-31) — Tax Provision: 13312.00
CKX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
CKX balance_sheet (quarterly, 2026-03-31) — Total Assets: 22315798.00
CKX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 21500656.00
CKX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 21500656.00
CKX income_statement (quarterly, 2026-03-31) — Total Expenses: 245499.00
CKX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 815142.00
CKX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4231213.00
CKX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 109954.00
CKX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -74839.00
CKX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 482360.00
CKX balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 49466.00
CKX balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 620216.00
CKX balance_sheet (quarterly, 2026-03-31) — Working Capital: 17379397.00
CL cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -55000000.00
CL cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
CL income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
CL cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
CL cash_flow (annual, 2021-12-31) — Operating Gains Losses: 75000000.00
CL balance_sheet (annual, 2021-12-31) — Other Equity Interest: -1000000.00
CL income_statement (annual, 2021-12-31) — Other Operating Expenses: 4000000.00
CL income_statement (annual, 2021-12-31) — Other Special Charges: 75000000.00
CL cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: 0.00
CL cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
CL income_statement (annual, 2021-12-31) — Write Off: 10000000.00
CL income_statement (annual, 2022-12-31) — +Operating Expense: 6631000000.00
CL income_statement (annual, 2022-12-31) — +Total Revenue: 17967000000.00
CL balance_sheet (annual, 2022-12-31) — Accounts Payable: 1551000000.00
CL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1504000000.00
CL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -5276000000.00
CL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3546000000.00
CL balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -70000000.00
CL income_statement (annual, 2022-12-31) — Amortization: 80000000.00
CL income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 80000000.00
CL cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 721000000.00
CL income_statement (annual, 2022-12-31) — Basic Average Shares: 836400000.00
CL income_statement (annual, 2022-12-31) — Basic EPS: 2.13
CL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 832000000.00
CL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1825000000.00
CL cash_flow (annual, 2022-12-31) — Capital Expenditure: -696000000.00
CL cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -696000000.00
CL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 505000000.00
CL balance_sheet (annual, 2022-12-31) — Capital Stock: 1466000000.00
CL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 775000000.00
CL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 775000000.00
CL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1691000000.00
CL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -952000000.00
CL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1601000000.00
CL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2556000000.00
CL cash_flow (annual, 2022-12-31) — Change In Inventory: -333000000.00
CL cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -51000000.00
CL cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -115000000.00
CL cash_flow (annual, 2022-12-31) — Change In Receivables: -227000000.00
CL cash_flow (annual, 2022-12-31) — Change In Working Capital: -726000000.00
CL cash_flow (annual, 2022-12-31) — Changes In Cash: 3000000.00
CL balance_sheet (annual, 2022-12-31) — Common Stock: 1466000000.00
CL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -1691000000.00
CL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 401000000.00
CL cash_flow (annual, 2022-12-31) — Common Stock Payments: -1308000000.00
CL income_statement (annual, 2022-12-31) — Cost Of Revenue: 7719000000.00
CL balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1773000000.00
CL balance_sheet (annual, 2022-12-31) — Current Assets: 5113000000.00
CL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 108000000.00
CL balance_sheet (annual, 2022-12-31) — Current Debt: 25000000.00
CL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 133000000.00
CL balance_sheet (annual, 2022-12-31) — Current Liabilities: 4004000000.00
CL cash_flow (annual, 2022-12-31) — Deferred Income Tax: -78000000.00
CL cash_flow (annual, 2022-12-31) — Deferred Tax: -78000000.00
CL cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 545000000.00
CL income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 80000000.00
CL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 545000000.00
CL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 80000000.00
CL income_statement (annual, 2022-12-31) — Diluted Average Shares: 838800000.00
CL income_statement (annual, 2022-12-31) — Diluted EPS: 2.13
CL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1785000000.00
CL income_statement (annual, 2022-12-31) — EBIT: 2827000000.00
CL income_statement (annual, 2022-12-31) — EBITDA: 3372000000.00
CL income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 12000000.00
CL cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -60000000.00
CL balance_sheet (annual, 2022-12-31) — Employee Benefits: 1129000000.00
CL cash_flow (annual, 2022-12-31) — End Cash Position: 775000000.00
CL cash_flow (annual, 2022-12-31) — Financing Cash Flow: -952000000.00
CL balance_sheet (annual, 2022-12-31) — Finished Goods: 1508000000.00
CL cash_flow (annual, 2022-12-31) — Free Cash Flow: 1860000000.00
CL cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -47000000.00
CL income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 47000000.00
CL income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 22000000.00
CL balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -4055000000.00
CL balance_sheet (annual, 2022-12-31) — Goodwill: 3352000000.00
CL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 5272000000.00
CL balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1574000000.00
CL balance_sheet (annual, 2022-12-31) — Gross PPE: 9583000000.00
CL income_statement (annual, 2022-12-31) — Gross Profit: 10248000000.00
CL income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 721000000.00
CL cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 945000000.00
CL balance_sheet (annual, 2022-12-31) — Income Tax Payable: 317000000.00
CL income_statement (annual, 2022-12-31) — Interest Expense: 167000000.00
CL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 167000000.00
CL income_statement (annual, 2022-12-31) — Interest Income: 14000000.00
CL income_statement (annual, 2022-12-31) — Interest Income Non Operating: 14000000.00
CL cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 151000000.00
CL balance_sheet (annual, 2022-12-31) — Interest Payable: 59000000.00
CL balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -148000000.00
CL balance_sheet (annual, 2022-12-31) — Inventory: 2074000000.00
CL balance_sheet (annual, 2022-12-31) — Invested Capital: 9167000000.00
CL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1601000000.00
CL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1513000000.00
CL balance_sheet (annual, 2022-12-31) — Land And Improvements: 180000000.00
CL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 397000000.00
CL balance_sheet (annual, 2022-12-31) — Long Term Debt: 8741000000.00
CL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 9138000000.00
CL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1513000000.00
CL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -406000000.00
CL balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 6001000000.00
CL balance_sheet (annual, 2022-12-31) — Minority Interest: 405000000.00
CL income_statement (annual, 2022-12-31) — Minority Interests: -182000000.00
CL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -809000000.00
CL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -1308000000.00
CL balance_sheet (annual, 2022-12-31) — Net Debt: 7991000000.00
CL income_statement (annual, 2022-12-31) — Net Income: 1785000000.00
CL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1785000000.00
CL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1967000000.00
CL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1785000000.00
CL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1785000000.00
CL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1967000000.00
CL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1967000000.00
CL income_statement (annual, 2022-12-31) — Net Interest Income: -153000000.00
CL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -148000000.00
CL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1647000000.00
CL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1107000000.00
CL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -153000000.00
CL cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -18000000.00
CL cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 5000000.00
CL balance_sheet (annual, 2022-12-31) — Net PPE: 4307000000.00
CL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 47000000.00
CL cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 540000000.00
CL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -4871000000.00
CL balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 0.00
CL balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 135000000.00
CL balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 383000000.00
CL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 135000000.00
CL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 383000000.00
CL balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1129000000.00
CL income_statement (annual, 2022-12-31) — Normalized EBITDA: 4043000000.00
CL income_statement (annual, 2022-12-31) — Normalized Income: 2280869000.00
CL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2556000000.00
CL cash_flow (annual, 2022-12-31) — Operating Gains Losses: -47000000.00
CL income_statement (annual, 2022-12-31) — Operating Income: 3617000000.00
CL income_statement (annual, 2022-12-31) — Operating Revenue: 17967000000.00
CL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 830212606.00
CL balance_sheet (annual, 2022-12-31) — Other Current Assets: 760000000.00
CL balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 25000000.00
CL balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 15000000.00
CL balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -4055000000.00
CL balance_sheet (annual, 2022-12-31) — Other Equity Interest: -1000000.00
CL income_statement (annual, 2022-12-31) — Other Income Expense: -804000000.00
CL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1920000000.00
CL cash_flow (annual, 2022-12-31) — Other Non Cash Items: 49000000.00
CL balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 904000000.00
CL balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 271000000.00
CL income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -145000000.00
CL income_statement (annual, 2022-12-31) — Other Operating Expenses: 65000000.00
CL balance_sheet (annual, 2022-12-31) — Other Properties: 1577000000.00
CL income_statement (annual, 2022-12-31) — Other Taxes: -14000000.00
CL balance_sheet (annual, 2022-12-31) — Payables: 2001000000.00
CL balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3774000000.00
CL balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 82000000.00
CL income_statement (annual, 2022-12-31) — Pretax Income: 2660000000.00
CL cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 418000000.00
CL balance_sheet (annual, 2022-12-31) — Properties: 0.00
CL cash_flow (annual, 2022-12-31) — Purchase Of Business: -809000000.00
CL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -470000000.00
CL balance_sheet (annual, 2022-12-31) — Raw Materials: 666000000.00
CL balance_sheet (annual, 2022-12-31) — Receivables: 1504000000.00
CL income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 7254000000.00
CL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 545000000.00
CL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -406000000.00
CL cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -1308000000.00
CL income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 19000000.00
CL balance_sheet (annual, 2022-12-31) — Retained Earnings: 24573000000.00
CL cash_flow (annual, 2022-12-31) — Sale Of Investment: 322000000.00
CL cash_flow (annual, 2022-12-31) — Sale Of PPE: 47000000.00
CL income_statement (annual, 2022-12-31) — Selling General And Administration: 6565000000.00
CL balance_sheet (annual, 2022-12-31) — Share Issued: 1465706360.00
CL income_statement (annual, 2022-12-31) — Special Income Charges: -693000000.00
CL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 125000000.00
CL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 401000000.00
CL balance_sheet (annual, 2022-12-31) — Tangible Book Value: -4871000000.00
CL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -175131000.00
CL income_statement (annual, 2022-12-31) — Tax Provision: 693000000.00
CL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CL balance_sheet (annual, 2022-12-31) — Total Assets: 15731000000.00
CL balance_sheet (annual, 2022-12-31) — Total Capitalization: 9142000000.00
CL balance_sheet (annual, 2022-12-31) — Total Debt: 9271000000.00
CL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 806000000.00
CL income_statement (annual, 2022-12-31) — Total Expenses: 14350000000.00
CL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 14925000000.00
CL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 10618000000.00
CL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 10921000000.00
CL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 2893000000.00
CL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 450000000.00
CL income_statement (annual, 2022-12-31) — Total Unusual Items: -671000000.00
CL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -671000000.00
CL balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 635493754.00
CL balance_sheet (annual, 2022-12-31) — Treasury Stock: 25128000000.00
CL balance_sheet (annual, 2022-12-31) — Work In Process: 48000000.00
CL balance_sheet (annual, 2022-12-31) — Working Capital: 1109000000.00
CL income_statement (annual, 2023-12-31) — +Operating Expense: 7241000000.00
CL income_statement (annual, 2023-12-31) — +Total Revenue: 19457000000.00
CL balance_sheet (annual, 2023-12-31) — Accounts Payable: 1698000000.00
CL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1586000000.00
CL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -5704000000.00
CL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 3808000000.00
CL balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -80000000.00
CL income_statement (annual, 2023-12-31) — Amortization: 72000000.00
CL income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 72000000.00
CL cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CL income_statement (annual, 2023-12-31) — Basic Average Shares: 827400000.00
CL income_statement (annual, 2023-12-31) — Basic EPS: 2.78
CL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 775000000.00
CL balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2047000000.00
CL cash_flow (annual, 2023-12-31) — Capital Expenditure: -705000000.00
CL cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -705000000.00
CL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 515000000.00
CL balance_sheet (annual, 2023-12-31) — Capital Stock: 1466000000.00